<VariationArchive VariationID="2643779" VariationName="NM_014252.4(SLC25A15):c.98_101del (p.Met33fs)" VariationType="Deletion" Accession="VCV002643779" Version="7" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-07-15" DateCreated="2023-11-20" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2813865" VariationID="2643779">
      <GeneList>
        <Gene Symbol="SLC25A15" FullName="solute carrier family 25 member 15" GeneID="10166" HGNC_ID="HGNC:10985" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>13q14.11</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="40789611" stop="40812460" display_start="40789611" display_stop="40812460" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="41363546" stop="41386595" display_start="41363546" display_stop="41386595" Strand="+" />
          </Location>
          <OMIM>603861</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_014252.4(SLC25A15):c.98_101del (p.Met33fs)</Name>
      <CanonicalSPDI>NC_000013.11:40799096:AATGAA:AA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>13q14.11</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="40799097" stop="40799100" display_start="40799097" display_stop="40799100" variantLength="4" positionVCF="40799096" referenceAlleleVCF="CAATG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="41373233" stop="41373236" display_start="41373233" display_stop="41373236" variantLength="4" positionVCF="41373232" referenceAlleleVCF="CAATG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>M33fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.10" sequenceAccession="NC_000013" sequenceVersion="10" change="g.41373235_41373238del" Assembly="GRCh37">
            <Expression>NC_000013.10:g.41373235_41373238del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.11" sequenceAccession="NC_000013" sequenceVersion="11" change="g.40799099_40799102del" Assembly="GRCh38">
            <Expression>NC_000013.11:g.40799099_40799102del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012248.1" sequenceAccession="NG_012248" sequenceVersion="1" change="g.14689_14692del">
            <Expression>NG_012248.1:g.14689_14692del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_038258.1" sequenceAccession="NR_038258" sequenceVersion="1" change="n.2247_2250del">
            <Expression>NR_038258.1:n.2247_2250del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_038259.1" sequenceAccession="NR_038259" sequenceVersion="1" change="n.2076_2079del">
            <Expression>NR_038259.1:n.2076_2079del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_014252.4" sequenceAccession="NM_014252" sequenceVersion="4" change="c.98_101del" MANESelect="true">
            <Expression>NM_014252.4:c.98_101del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_055067.1" sequenceAccession="NP_055067" sequenceVersion="1" change="p.Met33fs">
            <Expression>NP_055067.1:p.Met33fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_014252.4(SLC25A15):c.98_101del (p.Met33fs) AND not provided" Accession="RCV003393287" Version="7">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-10-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_014252.4(SLC25A15):c.98_101del (p.Met33fs) AND Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome" Accession="RCV003615957" Version="1">
        <ClassifiedConditionList TraitSetID="1660">
          <ClassifiedCondition DB="MedGen" ID="C0268540">Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-01-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-10-01" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2023-11-20" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11552031</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19242930</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1660" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5287" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Ornithine translocase deficiency syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome</ElementValue>
                <XRef ID="Ornithine+translocase+deficiency+syndrome/5413" DB="Genetic Alliance" />
                <XRef ID="30287008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HHH syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ornithine translocase deficiency</ElementValue>
                <XRef ID="MONDO:0009393" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HHHS</ElementValue>
                <XRef Type="MIM" ID="238970" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HHH</ElementValue>
                <XRef Type="MIM" ID="238970" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome is a disorder of the urea cycle and ornithine degradation pathway. Clinical manifestations and age of onset vary among individuals even in the same family. Neonatal onset (~8% of affected individuals). Manifestations of hyperammonemia usually begin 24-48 hours after feeding begins and can include lethargy, somnolence, refusal to feed, vomiting, tachypnea with respiratory alkalosis, and/or seizures. Infantile, childhood, and adult onset (~92%). Affected individuals may present with: Chronic neurocognitive deficits (including developmental delay, ataxia, spasticity, learning disabilities, cognitive deficits, and/or unexplained seizures); Acute encephalopathy secondary to hyperammonemic crisis precipitated by a variety of factors; and Chronic liver dysfunction (unexplained elevation of liver transaminases with or without mild coagulopathy, with or without mild hyperammonemia and protein intolerance). Neurologic findings and cognitive abilities can continue to deteriorate despite early metabolic control that prevents hyperammonemia.</Attribute>
                <XRef ID="NBK97260" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2830" />
                <XRef ID="2830" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22649802</ID>
                <ID Source="BookShelf">NBK97260</ID>
              </Citation>
              <XRef ID="415" DB="Orphanet" />
              <XRef ID="C0268540" DB="MedGen" />
              <XRef ID="MONDO:0009393" DB="MONDO" />
              <XRef Type="MIM" ID="238970" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8225468" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2024-02-20">
        <ClinVarSubmissionID localKey="14736475|MedGen:C0268540" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004432162" DateUpdated="2024-02-20" DateCreated="2024-02-20" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-01-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11552031</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19242930</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with SLC25A15-related conditions. This variant is present in population databases (rs752415542, gnomAD 0.003%). This sequence change creates a premature translational stop signal (p.Met33Lysfs*2) in the SLC25A15 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC25A15 are known to be pathogenic (PMID: 11552031, 19242930).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC25A15" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000013.10:g.41373233_41373236del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268540" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7713289" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="178053|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004133080" DateUpdated="2024-07-15" DateCreated="2023-11-20" Type="SCV" Version="7" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>SLC25A15: PVS1, PM2, PM3:Supporting</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC25A15" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="13" alternateAllele="A" referenceAllele="ATGAA" start="41373234" stop="41373238" variantLength="5" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7713289" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8225468" TraitType="Disease" MappingType="XRef" MappingValue="C0268540" MappingRef="MedGen">
        <MedGen CUI="C0268540" Name="Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

